Coeptis Therapeutics Holdings Inc (COEP) — Dilution Risk Analysis

Current Snapshot

Coeptis Therapeutics Holdings Inc (COEP) has a DilutionWatch score of 57/10 and is classified as HIGH risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
53,000,397 Source
Public Float
5,253,083 Source
Float as % of Outstanding
9.9%

Dilution Risk Score

Score: 57/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 2, 8-K 1, 4 7.

FormFiledAccession
xbrl 2026-06-30 xbrl-5779-xbrl_convertible
xbrl 2026-06-30 xbrl-5779-xbrl_warrant
8-K 2026-05-01 0001683168-26-003426
4 2026-04-30 0001683168-26-003316
4 2026-04-30 0001683168-26-003318
4 2026-04-30 0001683168-26-003320
4 2026-04-30 0001683168-26-003322
4 2026-04-30 0001683168-26-003324
4 2026-04-30 0001683168-26-003326
4 2026-04-30 0001683168-26-003328

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $20,000,000 Source
Cash runway 24 months Source
Three-year share count growth 9999.0% Source

DilutionWatch Analysis

Risk Level
HIGH (Score: 57/10) Source
Cash Runway
24 months Source
ATM Offering Capacity Remaining
$20,000,000 Source
Share Count Growth (3-Year)
9999.0% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.